 |
 | Vissza |
Nadarajah Ramesh; Ludman Peter; Appelman Yolande; Brugaletta Salvatore; Budaj Andrzej; Bueno Hector; Huber Kurt; Kunadian Vijay; Leonardi Sergio; Lettino Maddalena; Milasinovic Dejan; Gale Chris P.; Kollaborációs szervezet: NSTEMI Investigators; Ruzsa Zoltán; Becker F.; et al. (kollab. közrem.):
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
EUROPEAN HEART JOURNAL - QUALITY OF CARE AND CLINICAL OUTCOMES, 9 (1).
pp. 8-15.
ISSN 2058-5225
(2023)
Rao Sunil V.; Kirsch Bodo; Bhatt Deepak L.; Budaj Andrzej; Merkely Béla Péter; Kollaborációs szervezet: PACIFIC AMI Investigators; Falukozi József; Ruzsa Zoltán; Tomcsányi János; Csanádi Zoltán; Herczeg Béla; Kőszegi Zsolt; Vorobcsuk András; Kiss Róbert; Baranyai Csaba; Dezsi Csaba; Lupkovics Géza; et al. (kollab. közrem.):
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes Following Acute Myocardial Infarction.
CIRCULATION, 146 (16).
pp. 1196-1206.
ISSN 0009-7322
(2022)
Ray Kausik K.; Colhoun Helen M.; Szarek Michael; Baccara-Dinet Marie; Bhatt Deepak L.; Bittner Vera A.; Budaj Andrzej; Diaz Rene; Goodman Shaun G.; Hanotin Corinne; Harrington Robert A.; ODYSSEY OUTCOMES Committees and Investigators; Merkely Béla Péter; Ungi Imre; Katona András (kollab. közrem.):
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
LANCET DIABETES & ENDOCRINOLOGY, 7 (8).
pp. 618-628.
ISSN 2213-8587
(2019)
